Contrast-Induced Nephropathy after Intravenous Administration: Fact or Fiction?

Radiologic Clinics of North America

Volumn 47, Issue 5, 2009, Pages 789-800

  Katzberg, Richard W ^a   Lamba, Ramit ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acute renal failure; Contrast media; CT; Kidney function; Kidney injury

Indexed keywords

ACETYLCYSTEINE; CONTRAST MEDIUM; CREATININE; IODIXANOL; IOMEPROL; IOPAMIDOL; IOPROMIDE; PLACEBO;

CLINICAL TRIAL; CONTRAST INDUCED NEPHROPATHY; CREATININE BLOOD LEVEL; DEATH; HIGH RISK PATIENT; HUMAN; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW;

CLINICAL TRIALS AS TOPIC; CONTRAST MEDIA; CREATININE; HUMANS; INCIDENCE; INJECTIONS, INTRA-ARTERIAL; INJECTIONS, INTRAVENOUS; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; RISK FACTORS;

EID: 69649102128     PISSN: 00338389     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rcl.2009.06.002     Document Type: Review

References (48)

1. Bartels E.D., Baun G.C., Gammeltoft A., et al. Acute anuria following intravenous pyelography in a patient with myelomatosis. Acta Med Scand 150 (1954) 297-302
2. Mudge G.H. Nephrotoxicity of urographic radiocontrast drugs. Kidney Int 18 (1980) 540-552
3. McClennan B.L. Ionic and nonionic iodinated contrast media: evolution and strategies for use. Am J Roentgenol 155 (1990) 225-233
4. Morris T.W. X-ray contrast media: where are we now and where are we going?. Radiology 188 (1993) 11-16
5. Eloy R., Corot C., and Belleville J. Contrast media for angiography: physiochemical properties, pharmacokinetics and biocompatibility. Clin Mater 7 (1991) 89-97
6. Katzberg R.W. State of the art. Urography into the 21st century: new contrast media, renal handling, imaging characteristics, and nephrotoxicity. Radiology 204 (1997) 297-312
7. Stacul F. Current iodinated contrast media. Eur Radiol 11 (2001) 690-697
8. Idée J.-M., Pinès E., Prigent P., et al. Allergy-like reactions to iodinated contrast agents. A critical analysis. Fundam Clin Pharmacol 19 (2005) 263-281
9. Katayama H., Yamaguci K., Kozuka T., et al. Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on Safety of Contrast Media. Radiology 175 (1990) 621-628
10. Katzberg R.W., and Haller C. Contast-induced nephrotoxicity: clinical landscape. Kidney Int 69 (2006) 53-57
11. Mudge G.H. The maximum urinary concentration of diatrizoates. Invest Radiol 15 Suppl (1980) S67-S78
12. Morris T.W., and Katzberg R.W. Intravascular contrast media: properties and general effects. In: Katzberg R.W. (Ed). The contrast media manual (1992), Williams & Wilkins, Baltimore (MD) 1-18
13. Katzberg R.W. Contrast medium-induced nephrotoxicity: which pathway?. [Editorial]. Radiology 235 (2005) 752-755
14. Weisberg L.S., Kurnik P.B., and Kurnik B.R. Radiocontrast-induced nephropathy in humans: role of renal vasoconstriction. Kidney Int 41 (1992) 1408-1415
15. Guevera M., Fernández-Esparrach G., Allessandra C., et al. Effects of contrast media on renal function in patients with cirrhosis: a prospective study. Hepatology 40 (2004) 646-651
16. Agmon Y., Peleg H., Greenfeld Z., et al. Nitric oxide and prostanoids protect the renal outer medulla from radiocontrast toxicity in the rat. J Clin Invest 94 (1994) 1069-1075
17. Lancelot E., Idée J.M., Couturier V., et al. Influence of the viscosity of iodixanol on medullary and cortical blood flow in the rat kidney: a potential cause of nephrotoxicity. J Appl Toxicol 19 (1999) 341-346
18. Vaamonde C.A., Bier R.T., Papendick R., et al. Acute and chronic renal effects of radiocontrast in diabetic rats. Role of anesthesia and risk factors. Invest Radiol 24 (1989) 206-218
19. Tepel M., van der Geit M., Schwarzfeld C., et al. Prevention of radiocontrast-agent-induced reductions in renal function by acetyleysteine. N Engl J Med 343 (2000) 180-184
20. Nguyen S.A., Suranyi P., Ravenel J.G., et al. Iso-osmolality versus low-osmolality iodinated contrast medium at intravenous contrast-enhanced CT: effect on kidney function. Radiology 248 (2008) 97-113
21. Weisbord S.D., Mor M.K., Resnick A.L., et al. Incidence and outcomes of contrast-induced AKI following computed tomography. Clin J Am Soc Nephrol 3 (2008) 1274-1281
22. Barrett B.J., Katzberg R.W., Thomsen H.S., et al. Contrast-induced nephropathy in patients with chronic kidney disease undergoing computer tomography. A double blind comparison of iodixanol and iopamidol. Invest Radiol 41 (2006) 815-821
23. Thomsen H.S., Morcos S.K., Earley C.M., et al. The ACTIVE trial: comparison of the effects on renal function of iomeprol-400 and iodixanol-320 in patients with chronic kidney disease undergoing abdominal computed tomography. Invest Radiol 43 (2008) 170-178
24. Kuhn M.J., Chen N., Sahani D.V., et al. The PRDICT study: a randomized double-blind comparison of contrast-induced nephropathy after low- or iso-osmolar contrast agent exposure. Am J Roentgenol 181 (2008) 151-157
25. Bellomo R., Kellum J.A., and Ronco C. Defining and classifying acute renal failure: from advocacy to consensus and validation of RIFLE criteria. Intensive Care Med 33 (2007) 409-413
26. Mehta R.L., Kellum J.A., Shah S.V., et al. Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11 (2007) 1-8
27. Katzberg R.W., and Barrett B.J. Risk of iodinated contrast material-induced nephropathy with intravenous administration. Radiology 243 (2007) 622-628
28. Rudnick M.R., Goldfarb S., Wexler L., et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. Kidney Int 47 1 (1995) 254-261
29. Gruberg L., Mintz G.S., Mehran R., et al. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 36 (2000) 1542-1548
30. Rudnick M., and Feldman H. Contrast-induced nephropathy: what are the true clinical consequences. Clin J Am Soc Nephrol 3 (2008) 263-272
31. Levy E.M., Viscoli C.M., and Horwitz R.I. The effect of acute renal failure on mortality: a cohort analysis. JAMA 275 (1996) 1489-1494
32. Keeley E.C., and Grines C.L. Scraping of aortic debris by coronary guiding catheters. A prospective evolution in 1,000 cases. J Am Coll Cardiol 32 7 (1998) 1861-1865
33. Vidt D.G. Cholesterol emboli, a common cause of renal failure. Annu Rev Med 48 (1997) 375-385
34. Rao Q., and Newhouse J.H. Risk of nephropathy after intravenous contrast: a critical literature analysis. Radiology 239 (2006) 392-397
35. Cramer B.C., Parfrey P.S., Hutchinson T.A., et al. Renal function following infusion of radiologic contrast material: a prospective controlled study. Arch Intern Med 145 (1985) 87-89
36. Heller C.A., Knapp J., Halliday J., et al. Failure to demonstrate contrast nephrotoxicity. Med J Aust 155 (1991) 329-332
37. Newhouse J.H., Kho D., Rao Q.A., et al. Frequency of serum creatinine charges in the absence of iodinated contrast material: implications for studies of contrast nephrotoxicity. Am J Roentgenol 191 (2008) 376-382
38. Shafi T., Chon S.Y., Porush J.G., et al. Infusion intravenous pyelography and renal function: effects in patients with chronic renal insufficiency. Arch Intern Med 138 (1978) 1218-1221
39. Harkonen S., and Kjellstrand C.M. Exacerbation of diabetic renal failure following intravenous pyelography. Am J Med 63 6 (1977) 939-946
40. Smith H.J., Levorstad K., Berg K.J., et al. High dose urography in patients with renal failure: a double-blind investigation of iohexol and metrizoate. Acta Radiol Diagn 26 (1985) 213-220
41. Teruel J.L., Marcen R., Onaindia J.M., et al. Renal function impairment caused by intravenous urography: a prospective study. Arch Intern Med 141 (1981) 1271-1274
42. Bruce R.J., Djamali A., Shinki K., et al. Background fluctuation of kidney function versus contrast-induced nephrotoxicity. Am J Roentgenol 192 (2009) 711-718
43. Levey A.S., Bosch J.P., Lewis J.B., et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 130 (1999) 461-470
44. Levey A.S., Coresh J., Balk E., et al. National kidney foundation practice guidelines for chronic kidney disease: evolution, classification, and stratification. Ann Intern Med 139 (2003) 137-147
45. Herts B.R., Schneider E., Poggio E.D., et al. Identifying outpatients with renal insufficiency before contrast-enhanced CT by using estimated glomerular filtration rates versus serum creatinine levels. Radiology 248 (2008) 106-113
46. American College of Radiology Manual on Contrast Media, version 6.0. American College of Radiology website, Available at:. http://www.acr.org Accessed March 8, 2009
47. Mueller C. Prevention of contrast-induced nephropathy with volume supplementation. Kidney Int Suppl 100 (2006) S16-S19
48. Briguori C., and Marenzi G. Contrast-induced nephropathy: pharmacological prophylaxis. Kidney Int 69 (2006) 530-538